Madison Avenue Partners, LP Merrimack Pharmaceuticals Inc Transaction History

Madison Avenue Partners, LP

  • $501 Million
  • Q1 2024

A detailed history of Madison Avenue Partners, LP transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Madison Avenue Partners, LP holds 387,221 shares of MACK stock, worth $5.86 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
387,221
Previous 553,085 29.99%
Holding current value
$5.86 Million
Previous $7.42 Million 22.88%
% of portfolio
1.14%
Previous 1.51%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$13.06 - $15.0 $2.17 Million - $2.49 Million
-165,864 Reduced 29.99%
387,221 $5.72 Million
Q1 2023

May 15, 2023
BUY
$11.35 - $12.32 $6.28 Million - $6.81 Million
553,085 New
553,085 $6.8 Million

Others Institutions Holding MACK

# of Institutions
71
Shares Held
9.18M
Call Options Held
64K
Put Options Held
3.2K
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Madison Avenue Partners, LP Portfolio

Follow Madison Avenue Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Avenue Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Madison Avenue Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email